KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ABBV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

AbbVie stock price down 4.58% on Friday
(Updated on Apr 26, 2024)

Sell candidate since Apr 25, 2024 Loss -4.58% PDF

The AbbVie stock price fell by -4.58% on the last day (Friday, 26th Apr 2024) from $167.29 to $159.62. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 6.22% from a day low at $157.65 to a day high of $167.46. The price has risen in 6 of the last 10 days but is still down by -1.64% for this period. Volume has increased on the last day by 5 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 10 million shares were bought and sold for approximately $1.65 billion.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $158.37 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -2.98% during the next 3 months and, with a 90% probability hold a price between $153.66 and $174.94 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ABBV Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The AbbVie stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $166.17 and $173.03. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -12.34%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for AbbVie stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $9.81 between high and low, or 6.22%. For the last week, the stock has had daily average volatility of 2.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ABBV) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect AbbVie Inc to open at $161.58, and during the day (based on 14 day Average True Range), to move between $155.91 and $163.33, which gives a possible trading interval of +/-$3.71 (+/-2.33%) up or down from last closing price. If AbbVie Inc takes out the full calculated possible swing range there will be an estimated 4.65% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $167.90, some $8.28 (5.19%) from the current price of $159.62, our system finds the risk reward not very attractive.

Is AbbVie Inc stock A Buy?

AbbVie holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.037 Sell Candidate Unchanged

Predicted Opening Price for AbbVie Inc of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$161.58 ( 1.23%) $159.62

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ABBV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 171.39 7.37 %
R2 167.64 5.02 %
R1 165.32 3.57 %
Current price: 159.62
Support S1 157.83 -1.12 %
S2 155.51 -2.57 %
S3 151.77 -4.92 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 176.27 10.43 %
R2 173.29 8.56 %
R1 167.90 5.19 %
Current price 159.62
Support S1 0 .
S2 0 .
S3 0 .

ABBV Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Apr 12, 2024 Apr 12, 2024 May 15, 2024 $1.55 0.97%
2 Jan 15, 2024 Jan 15, 2024 Feb 15, 2024 $1.55 0.88%
3 Oct 27, 2023 Jan 12, 2024 Feb 15, 2024 $1.55 0.88%
4 Sep 08, 2023 Oct 12, 2023 Nov 15, 2023 $1.48 1.08%
5 Jun 22, 2023 Jul 14, 2023 Aug 15, 2023 $1.48 0.97%

FAQ

What is the symbol for AbbVie Stock and on which exchange is it traded?
The symbol for AbbVie is ABBV and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell AbbVie Stock?
AbbVie holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy AbbVie Stock?
AbbVie Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AbbVie Stock.

What's the current price of AbbVie Stock?
As of the end of day on the Apr 26, 2024, the price of an AbbVie (ABBV) share was $159.62.

What is the 52-week high and low for AbbVie Stock?
The 52-week high for AbbVie Stock is $182.89 and the 52-week low is $130.96.

What is the market capitalization of AbbVie Stock?
As of the Apr 26, 2024, the market capitalization of AbbVie is 296.212B.

When is the next earnings date for AbbVie?
The upcoming earnings date for AbbVie is Jul 25, 2024.
Click to get the best stock tips daily for free!

About AbbVie Inc

AbbVie AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ... ABBV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT